Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted ...

TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...

Last JavaScript-based TypeScript arrives in beta TypeScript 6.0 is intended to be the last release based on the current JavaScript codebase, before a Go-based compiler and language service debuts in ...

Get the latest Relay Therapeutics, Inc. (RLAY) stock news and headlines to help you in your trading and investing decisions.

Chart does not reflect overnight price.